Andrea Villa, Operational Board Member at Cancer Core Europe, shared on LinkedIn:
“Still hard to believe.
Our Review, ‘AI-based augmentation of oncology clinical trials’, has just been published in Nature Reviews Clinical Oncology.
In this work, we explore how AI could augment the entire oncology, clinicaltrial lifecycle, from trial design and patient recruitment to monitoring, evidence generation and the use of digitaltwins.
I’m extremely grateful to all my co-authors for their contributions, expertise and support throughout this journey. None of this would have been possible without their support and dedication.
A special thank you to Ashley Eadie, and Ravi B. Parikh for their incredible attention to detail, care and support throughout this journey. I truly could not have asked for better colleagues to work with.
But my special thank you goes to Arsela Prelaj, who believed in me from the very beginning and has been so much more than a colleague: a mentor, a guide and someone who has always encouraged me to grow.
Very proud of what we have achieved together, and excited for what comes next.”
Title: AI-based augmentation of oncology clinical trials
Authors: Andrea Villa, Ashley L. Eadie, David Synnott, Rebecca Romanò, Max Piffoux, Evelyn Yi Ting Wong, Naomi Scheinerman, Daniel S. W. Tan, Filippo Guglielmo Maria de Braud, Miriam Koopman, Jarushka Naidoo, Madhusmita Behera, Selen Bozkurt, Susan Halabi, Rodrigo Dienstmann, Loic Verlingue, Arsela Prelaj, Ravi B. Parikh.
Read The Full Paper.